Insider · CIK 0001752139
Daniel J. Becker
Files at ZURA (Zura Bio Ltd), SLRN (ACELYRIN, Inc.). First filing -, latest -.
In brief
Daniel J. Becker files SEC Form 4 as director at ZURA (Zura Bio Ltd), and also at SLRN (ACELYRIN, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Daniel J. Becker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | ZURA Zura Bio Ltd | AGrant or award Share Option (Right to Buy)derivative | +51,000 | $0.00 | $0 | 51,000 | Jun 22, 2026 |
| May 29, 2025 | ZURA Zura Bio Ltd | AGrant or award Share Option (Right to Buy)derivative | +51,000 | $0.00 | $0 | 51,000 | May 29, 2025 |
| May 21, 2025 | SLRN ACELYRIN, Inc. | DDisposition to issuer Common Stock | -2,999 | - | - | 0 | May 23, 2025 |
| May 21, 2025 | SLRN ACELYRIN, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -23,243 | - | - | 0 | May 23, 2025 |
| May 21, 2025 | SLRN ACELYRIN, Inc. | DDisposition to issuer Director Stock Option (right to buy)derivative | -92,158 | - | - | 0 | May 23, 2025 |
Questions about Daniel J. Becker
Answered from the filings on this page, as of the latest one.
Is Daniel J. Becker buying or selling?
Daniel J. Becker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Daniel J. Becker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel J. Becker has 0.
Where does Daniel J. Becker file Form 4?
Daniel J. Becker has filed Form 4 at ZURA (Zura Bio Ltd); SLRN (ACELYRIN, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.